De Silva Rajiv

Pres & COO, Specialty Pharm at BHC; Chief Operating Officer at VALEANT PHARMACEUTICALS INTERNATIONAL

Sold, on record
$23.1M
Dollars the filings state
Form 4 sales
4
Latest Nov 8, 2012
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale VALEANT PHARMACEUTICALS INTERNATIONALPlan not stated
    Jun 9, 2010 2010

    Sold 23,000 shares at $45.24 ($1M)

    De Silva Rajiv, Chief Operating Officer

    Sold 19.2% of holdings ($5.4M position)96,488 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale BHCUnusual
    Dec 1, 2010 +175 days

    Sold 219,897 shares at $27.00 ($5.9M)

    De Silva Rajiv, President & COO Spec. Pharma.

    Sold 43% of holdings ($13.8M position)291,794 shares leftFirst sale on recordFiling

  3. 3 Form 4 sale BHCUnusual
    Nov 6, 2012 +706 days

    Sold 220,696 shares at $54.38 ($12M)

    De Silva Rajiv, Pres. & COO, Specialty Pharma

    Sold 45.4% of holdings ($26.4M position)265,217 shares leftFiling

  4. 4 Form 4 sale BHCPlan not stated
    Nov 8, 2012 +2 days

    Sold 76,344 shares at $54.04 ($4.1M)

    De Silva Rajiv, Pres & COO, Specialty Pharm

    Sold 22.4% of holdings ($18.5M position)265,217 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by De Silva Rajiv
Source
Nov 8, 2012Nov 9, 2012BHCPres & COO, Specialty PharmForm 4 sale76,344$4.1M22.4%Plan not statedSEC
Nov 6, 2012Nov 8, 2012BHCPres. & COO, Specialty PharmaForm 4 sale220,696$12M45.4%UnusualSEC
Dec 1, 2010Dec 2, 2010BHCPresident & COO Spec. Pharma.Form 4 sale219,897$5.9M43.0%UnusualSEC
Jun 9, 2010Jun 11, 2010VALEANT PHARMACEUTICALS INTERNATIONALChief Operating OfficerForm 4 sale23,000$1M19.2%Plan not statedSEC